Tirzepatide/Pyridoxine 30mg/50mgB6/2ML

Description

Tirzepatide is a novel medication developed for the treatment of type 2 diabetes. It is a dual GIP and GLP-1 receptor agonist, meaning it mimics two incretin hormones that help regulate insulin and glucose metabolism. Tirzepatide has shown significant efficacy in lowering blood sugar levels and promoting weight loss in clinical trials. It is administered via subcutaneous injection and is often considered for patients who have not achieved adequate glycemic control with other diabetes therapies.

Pyridoxine is the 4-methanol form of vitamin B6, an important water-soluble vitamin that is naturally present in many foods. As its classification as a vitamin implies, Vitamin B6 (and pyridoxine) are essential nutrients required for normal functioning of many biological systems within the body. While many plants and microorganisms are able to synthesize pyridoxine through endogenous biological processes, animals must obtain it through their diet. More specifically, pyridoxine is converted to pyridoxal 5-phosphate in the body, which is an important coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid.

Additional information